PODD fell to $161.28 on July 10, 2026, as product recalls and competition concerns weighed on the $11.17 billion company.
Insulet Corporation (NASDAQ:PODD) closed at $161.28 on July 10, 2026, reflecting a 44.77% decline over the past 52 weeks. The company, valued at $11.17 billion, faced pressure from broad medtech sector weakness, a minor product recall, and quality issues.
Revenue in Q1 2026 reached $762 million, up 34% year-over-year, but hedge fund ownership dropped to 55 from 60 in the prior quarter. ClearBridge SMID Cap Growth Strategy noted concerns over future competition in its Q2 2026 investor update.
The stock’s one-month return stood at 8.87%, though longer-term performance lagged due to sector-wide challenges and company-specific headwinds.